Cargando…
Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wiley Publishing Asia Pty Ltd
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345971/ https://www.ncbi.nlm.nih.gov/pubmed/37157122 http://dx.doi.org/10.1111/1753-0407.13409 |
| _version_ | 1785073210482491392 |
|---|---|
| author | Wasif, Uzayr Al‐Shehab, Usmaan Lo, David F. |
| author_facet | Wasif, Uzayr Al‐Shehab, Usmaan Lo, David F. |
| author_sort | Wasif, Uzayr |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10345971 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Wiley Publishing Asia Pty Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103459712023-07-15 Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes Wasif, Uzayr Al‐Shehab, Usmaan Lo, David F. J Diabetes Letters to the Editor Wiley Publishing Asia Pty Ltd 2023-05-08 /pmc/articles/PMC10345971/ /pubmed/37157122 http://dx.doi.org/10.1111/1753-0407.13409 Text en © 2023 The Authors. Journal of Diabetes published by Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Wasif, Uzayr Al‐Shehab, Usmaan Lo, David F. Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes |
| title | Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes |
| title_full | Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes |
| title_fullStr | Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes |
| title_full_unstemmed | Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes |
| title_short | Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes |
| title_sort | critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345971/ https://www.ncbi.nlm.nih.gov/pubmed/37157122 http://dx.doi.org/10.1111/1753-0407.13409 |
| work_keys_str_mv | AT wasifuzayr criticalcommentaryontheassociationbetweenthiazolidinedioneuseanddementiariskinpatientswithtype2diabetes AT alshehabusmaan criticalcommentaryontheassociationbetweenthiazolidinedioneuseanddementiariskinpatientswithtype2diabetes AT lodavidf criticalcommentaryontheassociationbetweenthiazolidinedioneuseanddementiariskinpatientswithtype2diabetes |